Who
Ian Hodgson
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Corbus Pharmaceuticals Holdings.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $52K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Jan 2026
- Last trade
- 17 Feb 2026
- Last filed
- 18 Feb 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 18 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $6,253847 at $7.38 | filing |
| 17 Feb 2026filed 18 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $6,251847 at $7.38 | filing |
| 3 Feb 2026filed 4 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $20K2,415 at $8.09 | filing |
| 3 Feb 2026filed 4 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $20K2,415 at $8.09 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —28,365 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,095 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,095 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —28,365 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.